Side-by-side comparison of AI visibility scores, market position, and capabilities
Boston YC W23 eBPF-based auto-instrumentation for OpenTelemetry on Kubernetes; $13M+ Sep 2024 Venture Guides/Salesforce Ventures backed by Chronosphere/Honeycomb/LightStep founders competing with Datadog for zero-code distributed tracing observabi...
Odigos Technologies is a Boston, Massachusetts-based enterprise observability platform — backed by Y Combinator (W23) with $13 million+ in funding in September 2024 led by Venture Guides with Salesforce Ventures, Mango Capital, Firestreak Ventures, and angels including Martin Mao (Chronosphere co-founder), Christine Yen (Honeycomb co-founder), and Ben Sigelman (distributed tracing pioneer, LightStep founder) — providing engineering teams with an eBPF-based OpenTelemetry instrumentation platform that automatically instruments Kubernetes-deployed applications for distributed tracing, metrics, and logs collection without requiring code changes, supporting multiple languages and frameworks for instant observability across cloud-native architectures. Founded in 2023 by Eden Federman and Ari Recht with a 16-person team.
Automated end-to-end test generation from real user session recordings; $1M revenue with April 2025 M&A offer for zero-effort visual regression testing competing with Playwright and Percy.
Meticulous is a London-based test automation company that automatically generates end-to-end browser tests by recording actual user sessions — capturing real user flows through a JavaScript SDK installed on the application, then automatically generating and maintaining visual screenshot tests that detect UI regressions without requiring developers to write or maintain test code manually. Founded in 2021, Meticulous achieved $1 million in revenue in 2024 and received an undisclosed M&A acquisition offer in April 2025, serving web development teams and QA engineers who want automated visual regression testing with zero test writing effort.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.